Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126272151 | 12627215 | 1 | I | 2016 | 20160801 | 20160805 | 20160805 | EXP | US-ALLERGAN-1664859US | ALLERGAN | 59.00 | YR | M | Y | 94.33000 | KG | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126272151 | 12627215 | 1 | PS | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | UNK, UNK | U | U | 40148 | TABLET | |||||||
| 126272151 | 12627215 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 160 MG, UNK | U | 0 | 160 | MG | |||||||
| 126272151 | 12627215 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | U | 0 | ||||||||||
| 126272151 | 12627215 | 4 | C | SUCRALFATE. | SUCRALFATE | 1 | Oral | 1G, 1 IN 1 DAY | U | 0 | 1 | G | QD | ||||||
| 126272151 | 12627215 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | U | 0 | ||||||||||
| 126272151 | 12627215 | 6 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 60 MG, 1 IN 5 DAYS | U | 0 | 60 | MG | |||||||
| 126272151 | 12627215 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 40 MG, 1 IN 5 DAYS | U | 0 | 40 | MG | |||||||
| 126272151 | 12627215 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, 1 IN 5 DAYS | U | 0 | 20 | MG | |||||||
| 126272151 | 12627215 | 9 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 3 IN 1 DAY | U | 0 | ||||||||||
| 126272151 | 12627215 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, 2 IN 1 DAY | U | 0 | 20 | MG | |||||||
| 126272151 | 12627215 | 11 | C | DOXYCYCLINE MONOHYDRATE | DOXYCYCLINE | 1 | Oral | WAIT TWO HOURS BEFORE TAKING MULTIVITAMIN 2 IN1 DAY | U | 0 | |||||||||
| 126272151 | 12627215 | 12 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | UNK, 2 IN 1 DAY | U | 0 | |||||||||
| 126272151 | 12627215 | 13 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | Oral | 325 MG, EVERY 4 TO 6 HOURS AS NEEDED | U | 0 | 325 | MG | |||||||
| 126272151 | 12627215 | 14 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, 1 IN 1 DAY | U | 0 | 25 | MG | QD | ||||||
| 126272151 | 12627215 | 15 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, 1 IN 1 DAY | U | 0 | 81 | MG | QD | |||||||
| 126272151 | 12627215 | 16 | C | BRILINTA | TICAGRELOR | 1 | Oral | 90 MG, 2 IN 2 DAY | U | 0 | 90 | MG | |||||||
| 126272151 | 12627215 | 17 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 30 MG, 2 IN 1 DAY | U | 0 | 30 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126272151 | 12627215 | 1 | Product used for unknown indication |
| 126272151 | 12627215 | 2 | Crohn's disease |
| 126272151 | 12627215 | 4 | Product used for unknown indication |
| 126272151 | 12627215 | 5 | Product used for unknown indication |
| 126272151 | 12627215 | 6 | Product used for unknown indication |
| 126272151 | 12627215 | 9 | Product used for unknown indication |
| 126272151 | 12627215 | 10 | Product used for unknown indication |
| 126272151 | 12627215 | 11 | Product used for unknown indication |
| 126272151 | 12627215 | 12 | Product used for unknown indication |
| 126272151 | 12627215 | 13 | Product used for unknown indication |
| 126272151 | 12627215 | 14 | Product used for unknown indication |
| 126272151 | 12627215 | 15 | Product used for unknown indication |
| 126272151 | 12627215 | 16 | Product used for unknown indication |
| 126272151 | 12627215 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126272151 | 12627215 | OT |
| 126272151 | 12627215 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126272151 | 12627215 | Abdominal discomfort | |
| 126272151 | 12627215 | Adverse drug reaction | |
| 126272151 | 12627215 | Constipation | |
| 126272151 | 12627215 | Cough | |
| 126272151 | 12627215 | Dermatitis | |
| 126272151 | 12627215 | Dry skin | |
| 126272151 | 12627215 | Dyspnoea | |
| 126272151 | 12627215 | Eczema | |
| 126272151 | 12627215 | Erythema | |
| 126272151 | 12627215 | Feeling hot | |
| 126272151 | 12627215 | Hypersensitivity | |
| 126272151 | 12627215 | Immunodeficiency | |
| 126272151 | 12627215 | Inflammation | |
| 126272151 | 12627215 | Lichenification | |
| 126272151 | 12627215 | Lymphadenopathy | |
| 126272151 | 12627215 | Mass | |
| 126272151 | 12627215 | Melanocytic naevus | |
| 126272151 | 12627215 | Nausea | |
| 126272151 | 12627215 | Pain of skin | |
| 126272151 | 12627215 | Peripheral swelling | |
| 126272151 | 12627215 | Pulmonary function test abnormal | |
| 126272151 | 12627215 | Purulent discharge | |
| 126272151 | 12627215 | Rash maculo-papular | |
| 126272151 | 12627215 | Rash pustular | |
| 126272151 | 12627215 | Rash vesicular | |
| 126272151 | 12627215 | Scab | |
| 126272151 | 12627215 | Skin plaque | |
| 126272151 | 12627215 | Stent placement | |
| 126272151 | 12627215 | Tachycardia | |
| 126272151 | 12627215 | Wound | |
| 126272151 | 12627215 | Wound secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126272151 | 12627215 | 2 | 20160106 | 20160106 | 0 | |
| 126272151 | 12627215 | 3 | 20160302 | 0 |